⚡ TL;DR — VUKE in 30 Seconds
VUKE (Vanguard FTSE 100 UCITS ETF) is a low-cost, physically-replicated ETF that tracks the UK’s 100 largest publicly listed companies.
Expense ratio: just 0.09% per year. Dividend yield: ~3.0–3.3% paid quarterly. AUM: over £4.5 billion.
Total return over the past year: approximately 24% (GBP). Average annual return since 2012 inception: ~8.8%.
Best for: income investors, value-oriented investors, and those seeking low-cost UK equity exposure.
Not ideal for: high-growth seekers or investors who want heavy technology sector weighting.
If you are looking for a simple, low-cost way to own a slice of the UK stock market, a VUKE ETF review is exactly where you should start. This fund from Vanguard is one of the most widely held FTSE 100 trackers available — and for good reason.
But ‘popular’ does not automatically mean ‘right for you’. In this holistic review, we cover everything you need to know: how VUKE works, what it holds, how it has performed, what dividends you can expect, the risks you should understand, and who this ETF is actually designed to serve.
Want the big picture on the index itself first? Read our full explainer: What Is the FTSE 100?
What Is VUKE?
VUKE is the London Stock Exchange ticker for the Vanguard FTSE 100 UCITS ETF (GBP) Distributing. It is a passively managed exchange-traded fund that aims to replicate, as closely as possible, the total return of the FTSE 100 Index.
The FTSE 100 is a market-capitalisation-weighted index of the 100 largest companies listed on the London Stock Exchange. It includes global giants headquartered in or cross-listed in the UK: companies like AstraZeneca, HSBC, Shell, Unilever, and BAE Systems.
VUKE does not try to beat the market. It simply owns the market — all 100 companies — in proportion to their size. This is called full physical replication, and it is regarded as the gold standard of index-tracking accuracy.
| Key Fact | Detail |
|---|---|
| Full Name | Vanguard FTSE 100 UCITS ETF (GBP) Distributing |
| Ticker | VUKE (LSE) |
| ISIN | IE00B810Q511 |
| Index Tracked | FTSE 100 |
| Fund Domicile | Ireland |
| Inception Date | 22 May 2012 |
| Replication Method | Full Physical |
| Dividend Policy | Distributing — paid quarterly |
| Total Expense Ratio | 0.09% per year |
| Assets Under Management | ~£4.5–£4.6 billion (EUR ~4.55B) |
| Dividend Yield (TTM) | ~3.0–3.3% |
| Management Style | Passive |
How Does the VUKE ETF Work?
VUKE uses full physical replication to track the FTSE 100. In practice, this means Vanguard’s Ireland-domiciled fund buys shares in all 100 constituent companies and holds them directly. There is no complex derivative engineering or sampling involved.
As the FTSE 100 is rebalanced — typically quarterly — VUKE adjusts its holdings accordingly. Companies that grow large enough enter the index; companies that shrink drop out. The fund handles this automatically, so investors never need to rebalance or trade manually.
Because VUKE is domiciled in Ireland, it benefits from Irish tax treaty rates on UK dividend withholding taxes. This is a structural efficiency that the vast majority of VUKE investors will never see directly, but which helps minimise drag on the fund’s dividend distributions.
Sector Breakdown and Top Holdings
One of the most important things to understand about a FTSE 100 ETF review is what you are actually buying. The FTSE 100 is not a technology index. It is tilted heavily towards financials, energy, consumer staples, and healthcare — old-economy sectors that generate large, predictable cash flows.
| Sector | Approx. Weight |
|---|---|
| Finance (Banks, Insurers) | ~21.9% |
| Consumer Non-Durables (Staples) | ~14.7% |
| Health Technology (Pharma) | ~12.3% |
| Energy Minerals (Oil & Gas) | ~9.8% |
| Electronic Technology | ~8.1% |
| Commercial Services | ~5.3% |
| Utilities | ~4.6% |
| Non-Energy Minerals (Mining) | ~4.4% |
| Technology Services | ~3.4% |
| Consumer Services | ~3.2% |
The top 10 holdings account for nearly 50% of the fund — a natural result of market-cap weighting, where the biggest companies command the largest allocations.
| Company | Sector | Approx. Weight |
|---|---|---|
| AstraZeneca | Pharmaceuticals | ~8–9% |
| HSBC Holdings | Banking | ~8–9% |
| Shell | Oil & Gas | ~6–8% |
| Unilever | Consumer Staples | ~4% |
| Rolls-Royce Holdings | Aerospace & Defence | ~4% |
| British American Tobacco | Consumer Staples (Tobacco) | ~3–4% |
| GSK | Pharmaceuticals | ~3% |
| BP | Oil & Gas | ~3% |
| Rio Tinto | Mining | ~3% |
| BAE Systems | Defence | ~2–3% |
📌 Key Observation
Despite being a ‘UK index’, most FTSE 100 companies derive the majority of their revenues internationally. AstraZeneca sells drugs globally. Shell operates across multiple continents. HSBC’s profits are dominated by Asia. Owning VUKE is, in many ways, owning a globally diversified pool of large-cap businesses that happen to be listed in London.
VUKE Dividend: What Income Can You Expect?
Dividend income is perhaps the strongest argument for VUKE over its accumulating counterpart. The fund currently distributes a dividend yield in the range of 3.0–3.3% on a trailing twelve-month basis, paid out quarterly.
The FTSE 100 has historically been one of the highest-yielding major indices in the world. The concentration of dividend-paying heavyweights — banks, oil majors, tobacco companies, and miners — drives consistent income that a pure growth index like the S&P 500 simply cannot match on yield alone.
| Dividend Metric | Detail |
|---|---|
| Distribution Frequency | Quarterly (4x per year) |
| TTM Dividend Yield | ~3.0–3.3% |
| Most Recent Payment (Apr 2026) | £0.362 per share |
| 5-Year Avg Dividend Growth Rate | ~3.5% per annum |
| 3-Year Avg Dividend Growth Rate | ~1.6% per annum |
⚠️ Important Note on Dividend Variability
FTSE 100 dividend payouts can fluctuate significantly. During the COVID-19 pandemic in 2020, many UK companies suspended or cut dividends sharply, which reduced VUKE’s distributions for that period. The 5-year average growth rate reflects recovery from that trough. Always treat forward yield estimates as approximate, not guaranteed.
VUKE Performance History
A complete VUKE ETF review must be honest about performance. VUKE is not a high-growth fund. It has delivered solid but unspectacular capital appreciation relative to US-heavy alternatives, while compensating with meaningful dividend income.
| Period | Total Return (incl. dividends, GBP) |
|---|---|
| 2025 (calendar year — full year) | ~26.2% |
| 2024 | ~9.6% |
| 2023 | ~7.0% |
| 2022 | ~5.4% |
| 2021 | ~17.7% |
| 2020 | ~-11.6% |
| 2019 | ~17.5% |
| Since Inception (2012) — CAGR | ~8.8% per annum |
| Trailing 1-Year Total Return | ~24% (LON listing, GBP) |
The 2025 returns were notable — driven by a combination of a strong UK equity market rally, continued GBP strength, and rotation toward value stocks as global investors looked beyond US mega-cap concentration. This cyclicality is a defining feature of VUKE: it can lag for years and then sprint during value-driven cycles.
Over the long run, an 8.8% annualised total return since 2012 is a respectable number, particularly for a passive fund with near-zero management cost.
VUKE vs VUKG: Which Should You Choose?
This is the most common question among new investors exploring this fund. VUKE and VUKG track the exact same index — the FTSE 100 — managed by the same issuer, with the same expense ratio of 0.09%. The only difference is in how dividends are handled.
| Feature | VUKE (Distributing) | VUKG (Accumulating) |
|---|---|---|
| Dividend Treatment | Paid out quarterly in cash | Automatically reinvested |
| Best For | Income investors, retirees | Long-term compounders, ISA holders |
| Tax Consideration | Dividends taxable when received | May be more efficient in tax-advantaged accounts |
| Complexity | Zero — income lands in your account | Zero — reinvestment is automatic |
For investors holding inside a Stocks and Shares ISA or SIPP in the UK, VUKG is typically the more tax-efficient choice — dividends are reinvested without triggering a taxable event. For investors who need regular income, or who hold in a general investment account and prefer to deploy dividends manually, VUKE is the natural choice.
VUKE vs iShares Core FTSE 100 UCITS ETF (ISF)
The main competitor to VUKE is the iShares Core FTSE 100 UCITS ETF, trading as ISF on the London Stock Exchange. Both track the same index. The key differences are marginal but worth noting for cost-conscious investors.
| Feature | VUKE (Vanguard) | ISF (iShares) |
|---|---|---|
| Expense Ratio | 0.09% | 0.07% |
| AUM | ~£4.5B | ~£9B+ |
| Dividend Policy | Distributing (quarterly) | Distributing (semi-annual) |
| Replication | Full Physical | Full Physical |
| Issuer | Vanguard (Ireland) | BlackRock (Ireland) |
iShares ISF has a marginally lower expense ratio (0.07% vs 0.09%) and a larger AUM, which can translate to tighter bid-ask spreads in active trading. However, VUKE’s quarterly dividend payment schedule is preferable for income investors who want more frequent cash distributions. Over long holding periods, the 0.02% fee difference is negligible for most private investors.
Pros and Cons of VUKE
✅ Advantages
Ultra-low cost: 0.09% TER is extremely competitive for a fully-replicated physical ETF.
Reliable dividend income: ~3.0–3.3% yield paid quarterly from mature, cash-generative blue chips.
Genuine diversification: 100 large-cap companies across financials, energy, healthcare, staples, and more.
Global revenue exposure: despite being a UK index, most FTSE 100 earnings are international.
Value orientation: lower P/E multiples than US indices — potentially more margin of safety.
Highly liquid: traded on LSE, Deutsche Boerse, SIX Swiss Exchange, and Borsa Italiana.Transparent, passive management: no manager risk, no style drift.
❌ Disadvantages
Weak technology exposure: no NVIDIA, Apple, Microsoft, or comparable US mega-cap tech names.
Concentration at the top: the top 10 stocks represent ~50% of the fund — highly concentrated.
Old-economy tilt: heavy banks, oil, tobacco, and mining exposure may underperform in growth-led markets.
Currency risk for non-GBP investors: returns are denominated in sterling; a falling GBP erodes gains.
Slower long-term capital growth than US indices: the S&P 500 has significantly outperformed over 10-year horizons.
Dividend variability: FTSE 100 dividends can be cut sharply during recessions (as seen in 2020).
Who Is VUKE Best Suited For?
After a thorough VUKE ETF review, the fund fits a fairly specific investor profile. If you match the description below, VUKE deserves serious consideration.
VUKE is a strong fit if you are a UK-based investor seeking regular quarterly income from a low-cost, transparent, fully-diversified UK equity fund. It also suits investors who want geographic diversification away from US market concentration and are comfortable with value-oriented sector exposure.
It is a weaker fit for investors primarily seeking maximum capital growth over the next decade. If you want aggressive compounding with heavy technology sector exposure, a global all-world ETF or a US large-cap fund will likely serve you better.
| Investor Type | VUKE Fit |
|---|---|
| UK income investor seeking quarterly dividends | ⭐⭐⭐⭐⭐ Excellent |
| Long-term compounder in an ISA (growth focus) | ⭐⭐⭐ Consider VUKG instead |
| Global diversifier avoiding US concentration | ⭐⭐⭐⭐ Good |
| Investor seeking AI/technology sector exposure | ⭐ Poor fit |
| Retiree needing passive income | ⭐⭐⭐⭐⭐ Excellent |
| Emerging markets enthusiast | ⭐ Poor fit |
| Value investor seeking low-PE blue chips | ⭐⭐⭐⭐ Good |
Should You Invest in VUKE?
The short answer: yes, if UK dividend income and value-oriented blue-chip exposure align with your goals.
VUKE is a well-constructed, genuinely low-cost product from one of the world’s most trusted asset managers. An 8.8% average annual return since inception, a 3%+ dividend yield, and a TER of just 0.09% is a compelling combination for the right investor.
The risks are real: technology underexposure, old-economy tilt, and dividend vulnerability during downturns. But for income-focused investors or those building a diversified global portfolio that doesn’t depend entirely on US mega-caps, VUKE earns its place.
One final note: VUKE works best as part of a broader, diversified strategy. It should complement — not replace — global equity exposure. Pair it with a world or all-world ETF if your goal is long-term wealth building with income.
Looking for the best individual FTSE 100 stocks to complement your ETF? Read: 10 Best FTSE 100 Stocks to Buy
Frequently Asked Questions About VUKE
1. What does VUKE stand for?
VUKE is the London Stock Exchange ticker symbol for the Vanguard FTSE 100 UCITS ETF (GBP) Distributing. The name refers to Vanguard’s UK equity fund structure under the European UCITS regulatory framework.
2. Is VUKE a good investment?
VUKE is a solid investment for income-oriented and value-focused investors who want broad UK equity exposure at minimal cost. It is less suited for investors prioritising aggressive capital growth, as the FTSE 100 significantly underperforms US-heavy indices over long horizons.
3. What is the dividend yield for VUKE?
As of current market data, VUKE’s trailing twelve-month dividend yield is approximately 3.0–3.3%. Dividends are paid quarterly. The exact yield fluctuates with share price movements and the dividend policies of underlying holdings.
4. What is the expense ratio for VUKE?
VUKE has a total expense ratio (TER) of 0.09% per annum. This means for every £10,000 invested, you pay approximately £9 per year in fund costs — extremely competitive by any standard.
5. What is the difference between VUKE and VUKG?
Both track the identical FTSE 100 Index with the same 0.09% expense ratio. VUKE distributes dividends as cash payments to investors each quarter. VUKG (the accumulating version) automatically reinvests dividends back into the fund. VUKG is often preferred for tax-advantaged accounts like ISAs, while VUKE suits income-seekers.
6. How many companies does VUKE hold?
VUKE holds approximately 100 to 103 companies at any given time, reflecting the FTSE 100 Index composition. It uses full physical replication, meaning it directly purchases shares in all index constituents rather than using derivatives.
7. Where is VUKE domiciled?
VUKE is domiciled in Ireland. Irish domicile is standard for UCITS ETFs distributed across the European Union, as it provides favourable tax treaty treatment and regulatory clarity for international investors.
8. How has VUKE performed over the long term?
Since its inception in May 2012, VUKE has delivered an average annual total return of approximately 8.8% (GBP, including dividends reinvested). Calendar year returns have ranged from -11.6% in 2020 to +26.2% in 2025 (full year). Long-term performance has been solid, though it trails the S&P 500 over comparable periods.
9. Is VUKE suitable for an ISA?
Yes. VUKE can be held within a Stocks and Shares ISA, sheltering dividends and capital gains from UK tax. However, many tax-aware investors prefer VUKG (the accumulating version) within an ISA, as automatic reinvestment avoids dividend drag and simplifies compounding.
10. Can non-UK investors buy VUKE?
VUKE is listed on multiple exchanges including the London Stock Exchange, Deutsche Boerse, SIX Swiss Exchange, and Borsa Italiana — so it is accessible to investors across Europe and beyond. Non-UK investors should be aware of currency risk, as the fund is priced in GBP. Returns will vary depending on your home currency.